MA53553A - Traitement post-chirurgical de la douleur - Google Patents

Traitement post-chirurgical de la douleur

Info

Publication number
MA53553A
MA53553A MA053553A MA53553A MA53553A MA 53553 A MA53553 A MA 53553A MA 053553 A MA053553 A MA 053553A MA 53553 A MA53553 A MA 53553A MA 53553 A MA53553 A MA 53553A
Authority
MA
Morocco
Prior art keywords
surgical pain
pain treatment
post surgical
post
treatment
Prior art date
Application number
MA053553A
Other languages
English (en)
Inventor
Thomas B Ottoboni
Barry D Quart
Original Assignee
Heron Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heron Therapeutics Inc filed Critical Heron Therapeutics Inc
Publication of MA53553A publication Critical patent/MA53553A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MA053553A 2018-09-07 2019-09-06 Traitement post-chirurgical de la douleur MA53553A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862728732P 2018-09-07 2018-09-07
US201962860190P 2019-06-11 2019-06-11

Publications (1)

Publication Number Publication Date
MA53553A true MA53553A (fr) 2021-07-14

Family

ID=68138775

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053553A MA53553A (fr) 2018-09-07 2019-09-06 Traitement post-chirurgical de la douleur

Country Status (12)

Country Link
US (1) US20200078363A1 (fr)
EP (1) EP3846811A1 (fr)
JP (1) JP2021536477A (fr)
KR (1) KR20210060492A (fr)
CN (1) CN112955144A (fr)
AU (1) AU2019337104A1 (fr)
BR (1) BR112021004331A2 (fr)
CA (1) CA3111570A1 (fr)
MA (1) MA53553A (fr)
MX (1) MX2021002556A (fr)
TW (1) TW202023567A (fr)
WO (1) WO2020051543A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11992484B2 (en) * 2013-07-22 2024-05-28 Hutchison Health, Llc Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
US11992485B2 (en) * 2013-07-22 2024-05-28 Hutchison Health, Llc Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
JP2021512091A (ja) * 2018-01-30 2021-05-13 ヘロン セラピューティクス， インコーポレイテッドＨｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． Ｎｋ−１受容体アンタゴニストのエマルジョン製剤の投与方法
CA3205758A1 (fr) * 2021-01-29 2022-08-04 William Taylor Compositions et methodes de traitement soutenu de la douleur
WO2023154293A1 (fr) * 2022-02-08 2023-08-17 Saint Cyr Michael Hector Formulations anesthésiques et méthodes
CN116041342B (zh) * 2022-12-30 2024-02-20 加立(深圳)生物科技有限公司 罗哌卡因/美洛昔康盐的一水合物i晶型、药物组合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004043479A1 (fr) * 2002-11-12 2004-05-27 Omeros Corporation Solution d'irrigation et methode d'inhibition de l'adhesion de cellules tumorales, de douleurs et d'inflammations
US20090285862A1 (en) * 2006-05-03 2009-11-19 Cnsbio Pty Ltd. Methods and composition for treatment of inflammatory pain
EP2175886A1 (fr) * 2007-06-28 2010-04-21 CNSBio Pty Ltd Procédés et compositions de combinaison pour le traitement d'une douleur neuropathique
US8992951B2 (en) * 2013-01-09 2015-03-31 Sapna Life Sciences Corporation Formulations, procedures, methods and combinations thereof for reducing or preventing the development, or the risk of development, of neuropathology as a result of trauma
KR102238495B1 (ko) * 2013-03-15 2021-04-09 헤론 테라퓨틱스 인코포레이티드 폴리오르토에스테르 및 비프로톤성 용매의 조성물
US9801945B2 (en) * 2014-04-21 2017-10-31 Heron Therapeutics, Inc. Long-acting polymeric delivery systems
US11083730B2 (en) * 2014-04-21 2021-08-10 Heron Therapeutics, Inc. Long-acting polymeric delivery systems
CN113908284B (zh) * 2014-04-21 2023-08-04 赫伦治疗有限公司 长效聚合物输送系统

Also Published As

Publication number Publication date
AU2019337104A1 (en) 2021-03-25
EP3846811A1 (fr) 2021-07-14
JP2021536477A (ja) 2021-12-27
CN112955144A (zh) 2021-06-11
KR20210060492A (ko) 2021-05-26
TW202023567A (zh) 2020-07-01
WO2020051543A1 (fr) 2020-03-12
MX2021002556A (es) 2021-06-15
US20200078363A1 (en) 2020-03-12
CA3111570A1 (fr) 2020-03-12
BR112021004331A2 (pt) 2021-08-03

Similar Documents

Publication Publication Date Title
MA53553A (fr) Traitement post-chirurgical de la douleur
MA45192A (fr) Traitement d'association
DK3360508T3 (da) Hjælpeanordning til dental behandling
GB2611267B (en) Tissue treatment device
GB202105990D0 (en) Tissue treatment device
ES2973657T3 (es) Dispositivo de fijación de punta de endoscopio
DK3897672T5 (da) Hbv kombinationsbehandling
DK3678714T3 (da) Vævsmanipuleret medicinsk indretning
MA43800A (fr) Octréotide par voie orale pour le traitement de maladies
DK3773558T3 (da) Kombinationsbehandling af artritisk sygdom
BR112019005539A2 (pt) métodos de tratamento de lesão renal aguda
MA51525A (fr) Traitement de minéraux
MA52627A (fr) Traitement du cancer
MA51678A (fr) Méthodes de traitement de l'amyotrophie musculaire
MA49440A (fr) Elément de cicatrisation dentaire
DK3403674T3 (da) Farmaceutiske sammensætninger til behandling af smerte
DK3863647T3 (da) Behandling af ondartet knoglesmerte med pentosanpolysulfat
JP1671730S (ja) 医療用加湿器用タブ用部品
MA41782A (fr) Traitement de patients atteints de diabète de type 2
MA52738A (fr) Méthodes de traitement de l'arthrite psoriasique
MA48625A (fr) Composés et méthodes de traitement de la douleur viscérale
IT201700082185A1 (it) Dispositivo medico ortopedico
MA56179A (fr) Traitement de synucléinopathies
DE112020002320A5 (de) Schmerzmedikament
IT201900024568A1 (it) Dispositivo di fissaggio per catetere